1. India Stocks

  2. •

    Industrials

  3. •

    Industrial - Distribution
Gujarat Inject (Kerala) Ltd.

Gujarat Inject (Kerala) Ltd.

GUJINJEC.BO
Gujarat Inject (Kerala) Ltd.IN flagBombay Stock Exchange
13.90
INR
-118.80
- -
203.62MMarket Cap
Gujarat Inject (Kerala) Ltd.
GUJINJEC.BO
(Bombay Stock Exchange)

Recent

price

13.90

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
- -
3.2
- -
- -
- -
0.02
0.05
0.35
6.29
13.11
- -
26.19
Revenue per Share
- -
0.02
-0.03
-0.01
- -
-0.21
- -
0.08
0.09
0.7
- -
1.31
Basic EPS, GAAP
- -
- -
-0.02
- -
- -
-0.22
- -
0.11
-6.55
-2.42
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-8.49
-8.53
-8.13
-8.54
-8.75
-8.75
-8.67
2.44
10.07
- -
10.55
Book Value per Share
- -
-1.54
-1.57
-1.51
-1.58
-1.8
-1.79
-1.71
9.29
6.89
- -
8.53
Tangible Book Value per Share
- -
5
5
5
5
5
5
5
9
15
- -
14
Basic Weighted Avg Shares
- -
16
- -
- -
- -
- -
- -
2
58
190
363
363
Sales/Revenue/Turnover
- -
0.63
- -
- -
- -
-982.24
-202.91
-216.1
0.78
5.65
6.35
6.34
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
-1
- -
- -
1
10
18
18
Net Income, GAAP
- -
- -
- -
- -
- -
- -
25.09
26.03
21.38
18.89
27.55
27.55
Effective Tax Rate (%)
- -
0.64
- -
- -
- -
-911.24
9.78
23.62
1.43
5.34
4.99
4.99
Profit Margin (%)
-4
-4
-5
-5
-5
-5
-5
-7
85
80
-133
-133
Working Capital
3
3
3
3
3
4
4
4
- -
- -
- -
- -
LT Debt
-8
-8
-8
-8
-8
-9
-9
-8
85
100
118
118
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
0.85
9.4
14.89
14.86
Return on Invested Capital (%)
- -
- -
- -
- -
-0.01
- -
-0.06
-1.14
-11.93
12.07
12.4
12.4
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
12.05
12.4
12.4
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
15
- -
15
Market Capitalization
290
496
1,084

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
73
- -
116
Cash, Cash Equivalents & STI
2
- -
7
Accounts Receivable, Net
70
- -
63
Inventories
- -
- -
- -
Total Current Liabilities
15
- -
248
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-107.43%
-218%
18.15%
Free Cash Flow
- -
-3,444.71%
-112.94%
Net Income, GAAP
- -
592.88%
78.34%
Sales/Revenue/Turnover
- -
863.08%
90.7%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2
- -
2
54
58
2025
30
86
32
42
190
2026
24
16
16
307
363

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.06
0.03
0.01
- -
0.09
2025
0.08
0.42
0.14
0.05
0.7
2026
0.05
0.05
0.03
1.12
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
General Commercial & Industrial S.A. (GEBKA.AT)
Western Pacific Minerals Ltd. (WPMLF)
Tavernier Resources Limited (TAVERNIER.BO)
Grafton Group plc (GROUF)
MSC Industrial Direct Co., Inc. (MSM)
Prizor Viztech Ltd. (PRIZOR.NS)
Business
Gujarat Inject (Kerala) Ltd. manufactures and markets pharmaceutical and medical products primarily focused on intravenous (IV) fluids, infusion and transfusion solutions; bulk drugs and formulation chemicals; medicinal preparations including vitamin and non-vitamin tablets, capsules, and liquid formulations; and medical equipment such as disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes, and diagnostic kits. The company operates manufacturing facilities in Kerala, including at Puddussey East, Kanjikode in Palghat district, where it holds State Industrial Area (SIA) registration for producing intravenous solutions in aseptic bottles. Gujarat Inject (Kerala) Ltd. also engages in the trade, import, export, stocking, and distribution of these pharmaceutical and medical products. Founded in 1991 and headquartered in Kerala, the company is a joint sector enterprise promoted by Gujarat Inject Limited, Baroda, and its associates in partnership with the Kerala State Industrial Development Corporation Limited, a wholly-owned subsidiary of the Government of Kerala. This strategic alliance situates the company within the pharmaceutical manufacturing industry, catering to healthcare providers and institutions across India. In recent developments, Gujarat Inject (Kerala) Ltd. has entered into an Investment Sale Agreement with Soleos Energy Private Limited as part of its strategic business operations. The company has reported significant growth in sales, indicating an expansion phase. It continues to focus on enhancing its pharmaceutical product portfolio and production capacities, specifically in intravenous fluids and associated medical disposables, reinforcing its presence in the healthcare and medical supplies sector. The company serves primarily the Indian market with a focus on Kerala and adjoining regions, offering a diversified range of pharmaceutical and medical products essential for hospital and healthcare applications. Gujarat Inject (Kerala) Ltd. maintains operational focus on compliance, product quality, and expansion of manufacturing capabilities to sustain its growth trajectory and market presence. This description captures Gujarat Inject (Kerala) Ltd.'s core business activities, product offerings, key partnerships, and recent strategic moves reflective of its current operational status and industry positioning.